Literature DB >> 16273797

Assessment of ankylosing spondylitis.

J Zochling1, J Braun.   

Abstract

Outcome measures for the assessment of patients with ankylosing spondylitis (AS) have been the subject of considerable research in the last decade, largely through the contributions of the ASessments in Ankylosing Spondylitis (ASAS) International Working Group. This review focuses on the measurement of disease activity, physical function and structural damage in AS, both in daily patient care and to measure treatment response in clinical trials. The ASAS Core Sets for assessment in AS are an important tool to guide disease monitoring, and the domains they contain are discussed, along with other possible concepts important to patient care, including imaging and health-related quality of life. In clinical trials, the assessment of disease response to therapy using the ASAS Response Criteria is a valuable means of determining treatment efficacy and allows comparison of response across trials and interventions.

Entities:  

Mesh:

Year:  2005        PMID: 16273797

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

1.  Detection of Chlamydophila pneumoniae in patients with arthritis: significance and diagnostic value.

Authors:  Carlo Contini; Anastasio Grilli; Lorenzo Badia; Viola Guardigni; Marcello Govoni; Silva Seraceni
Journal:  Rheumatol Int       Date:  2010-04-10       Impact factor: 2.631

2.  Evaluation of the effects of Global Postural Reeducation in patients with ankylosing spondylitis.

Authors:  Eliane Maria Silva; Sandra C Andrade; Maria J Vilar
Journal:  Rheumatol Int       Date:  2011-05-05       Impact factor: 2.631

3.  Role of matrix metalloproteinase-3 (MMP-3) and magnetic resonance imaging of sacroiliitis in assessing disease activity in ankylosing spondylitis.

Authors:  Eiman Soliman; W Labib; G el-Tantawi; A Hamimy; A Alhadidy; A Aldawoudy
Journal:  Rheumatol Int       Date:  2011-03-24       Impact factor: 2.631

4.  The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis.

Authors:  Ali Erhan Özdemirel; Serdar Can Güven; İsmihan Sunar; Zühre Sari Sürmeli; Alper Doğanci; Hüseyin Tutkak; Ayşe Peyman Yalçin Sayin; Şebnem Ataman
Journal:  Int J Clin Pract       Date:  2022-03-24       Impact factor: 3.149

5.  Translation and validation of non-English versions of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire.

Authors:  Lynda C Doward; Stephen P McKenna; David M Meads; James Twiss; Dennis Revicki; Robert L Wong; Michelle P Luo
Journal:  Health Qual Life Outcomes       Date:  2007-02-02       Impact factor: 3.186

6.  Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis.

Authors:  Keith A Betts; Jenny Griffith; Yan Song; Manish Mittal; Avani Joshi; Eric Q Wu; Arijit Ganguli
Journal:  Rheumatol Ther       Date:  2016-07-25

7.  Polymorphisms within Genes Coding for IL-17A and F and Their Receptor as Clinical Hallmarks in Ankylosing Spondylitis.

Authors:  Joanna Wielińska; Jerzy Świerkot; Katarzyna Kolossa; Bartosz Bugaj; Monika Chaszczewska-Markowska; Sławomir Jeka; Katarzyna Bogunia-Kubik
Journal:  Mediators Inflamm       Date:  2021-10-27       Impact factor: 4.711

8.  Validity of Simplified Ankylosing Spondylitis Disease Activity Scores (SASDAS) in Indian Ankylosing Spondylitis Patients.

Authors:  Nagma Bansal; Lalit Duggal; Neeraj Jain
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  IL-33 Gene Polymorphisms as Potential Biomarkers of Disease Susceptibility and Response to TNF Inhibitors in Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients.

Authors:  Milena Iwaszko; Joanna Wielińska; Jerzy Świerkot; Katarzyna Kolossa; Renata Sokolik; Bartosz Bugaj; Monika Chaszczewska-Markowska; Sławomir Jeka; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

10.  Exploring the Extracellular Vesicle MicroRNA Expression Repertoire in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with TNF Inhibitors.

Authors:  Joanna Wielińska; Rachel E Crossland; Piotr Łacina; Jerzy Świerkot; Bartosz Bugaj; Anne M Dickinson; Katarzyna Bogunia-Kubik
Journal:  Dis Markers       Date:  2021-09-30       Impact factor: 3.434

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.